The significance of ACEi therapy in chronic allograft nephropathy
Angiotensin II plays a crucial role in pathologic processes of chronic allograft nephropathy (CAN) leading to chronic and progressive renal allograft dysfunction (CRAD). Systemic and glomerular hypertensions together with proteinuria occur in CAN under conditions of JGA hypertrophy with up-regulated...
Main Authors: | Savin Marina, Petronić Vladimir |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2005-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2005/0370-81790502082S.pdf |
Similar Items
-
Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy
by: Luo Lei, et al.
Published: (2012-07-01) -
Usefulness of real-time sonoelastography for assessment of renal allograft fibrosis
by: Ram Dayal Sahu, et al.
Published: (2020-01-01) -
Crystalline nephropathy in renal transplant: A series of 4 cases
by: K Mnif, et al.
Published: (2018-01-01) -
High-Throughput Proteomic Approaches to the Elucidation of Potential Biomarkers of Chronic Allograft Injury (CAI)
by: Hilary Cassidy, et al.
Published: (2013-09-01) -
ANTIOXIDANTS IN TREATMENT OF CHRONIC RENAL ALLOGRAFT DYSFUNCTION
by: R.O. Zograbian
Published: (2014-02-01)